[1] Laporte DM,Mont MA,Mohan,et al.Multifocal osteonecrosis.J Rheumatol.1998;25(10): 1968-1974.[2] Chernetsky SG,Mont MA,Laporte DM,et al.Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin Orthop Relat Res.1999;12(368):149-161.[3] Jones LC, Hungerford DS.The pathogenesis of osteonecrosis. Instr Course Lect. 2007;56(12):179-196.[4] 刘万林,郝廷,冯卫,等.家兔激素性股骨头坏死血管壁中差异表达基因的研究[J].中华创伤骨科杂志,2008,10(11):1058-1061.[5] 刘万林,郭文通,李文琪,等.激素性股骨头缺血坏死发病机理及其研究进展[J].中国矫形外科杂志, 2000,7(2):169-172.[6] 白志刚,刘万林,苏秀兰,等.非创伤性股骨头坏死血管内皮生长因子mRNA与骨形态发生蛋白-2表达的实验研究[J].中华实验外科杂志,2008,25(11):1528.[7] 白志刚,刘万林,苏秀兰,等.VEGFmRNA与BMP-2在非创伤性股骨头坏死中表达的研究[J].中国矫形外科杂志, 2009,17(3): 224-227.[8] 白志刚,刘万林,苏秀兰.细胞因子治疗非创伤性股骨头缺血坏死的研究进展[J].中国矫形外科杂志,2006,14(3):213-215[9] 冯卫,刘万林,苏秀兰,等.激素性股骨头缺血坏死与血管壁中主要促血管生长因子生理活性关系的实验研究[J].中华创伤骨科杂志,2008,10(10):960-964.[10] Nishida K, Yamamoto T, Motomura G, et al.Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits:a preliminary histological study. Clin Orthop Relat Res. 2008; 466(5): 1054-1058.[11] Takano-Murakami R, Tokunaga K, Kondo N,et al. Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats. Tohoku J Exp Med. 2009;217(1):51-58.[12] Yin L, Li YB, Wang YS. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chin Med J.2006;119(7): 581- 588. [13] Akita T, Murohara T, Ikeda H,et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest. 2003;83(1): 65- 73.[14] Siler U, Rousselle P, Muller CA,et al. Laminin gamma 2 chain as a stromaral cell marker of the human bone marrow microenvironment. Br J Haematol. 2002;119(1):212-220.[15] Boss JH, Misselevich I. Osteonecrosis of the femoral head of laborator animals:the lessons from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol. 2003;40(4):345-354.[16] Miyanishi K, Yamamoto T, Irisa T, et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis.Bone. 2001;30(1): 185-190.[17] Jones JP Jr. Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res. 1992;14(277):41-53.[18] 王峰,张元和.非创伤性股骨头缺血性坏死病因及发病机理研究进展[J].实用诊断与治疗杂志,2007,21(2):121-123.[19] Yun Si, Yoon HY, Jeong SY, et al. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009; 27(2):140-148.[20] O’Brien CA, Jia D, Plotkin Li, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004; 145(4):1835-1841.[21] Kerachian MA, Séquin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009; 114(3-5):121-128.[22] Calder JD, Buttery L, Revell PA, et al. Apoptosis-a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86(8):1209-1213.[23] Patil MA, Chua MS, Pan KH, et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene. 2005;24(23):3737-3747.[24] Sato H, Suzuki H, Toyota M, et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis. 2007;28(12): 2459-2466.[25] 李子荣,孙伟,张念非,等.SARS患者骨坏死-皮质激素与骨坏死关系[J].中日友好医院学报,2004, 12(2):34-35.[26] Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in human acute myocardial infarction .Circulation. 1997;95(2):320-323.[27] Toyoda Y, Shida T, Wakita N, et al. Evidence of apoptosis induced by myocardial ischemia: A case of ventricular septal rupture following acute myocardial infarction. Cardiology. 1998;90(2):149-151.[28] Sloviter RS.Apoptosis: a guide for the perplexed. Trends Pharmacol Sci. 2002;23(1): 19-24.[29] Sato M, Sugano N, Ohzono K, et al. Apoptosis and expression of stress protein (ORP150, HO1)during development of ischaemic osteonecrosis in the rat. J Bone Joint Surg Br. 2001; 83(5):751-759.[30] Moraes LA, Paul-Clark MJ, Rickman A, et al. Ligand-specific glucocorticoid receptor activation in human platelets. Blood. 2005;106(13):4167-4175.[31] Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85(8):2907-2912.[32] Weinstein RS, Manolagas SC. Apoptosis in glucocorticoid-induced bone disease . Current Opinion in Endecrinol Diabetes. 2005;12(3):219-223.[33] Barbosa V, Sievers RE, Zaugg CE, et al. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J. 1996; 131(2):224-230.[34] Wolfe CL, Sievers RE, Visseren FL, et al.Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 1993;87(3):881-892.[35] 王坤正,毛履真,胡长根,等.激素性股骨头缺血坏死发病机制的实验研究[J].中华外科杂志,1994,32(9):515-517[36] Gonzalez-Sancho JM, Aguilera O, Garcia JM, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005;24(6):1098-1103.[37] Chamorro MN, Schwartz DR, Vonica A, et al. FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J. 2005; 24(1): 73-84.[38] Oyama T, Yamada Y, Hata K, et al. Further upregulation of beta-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+mice. Carcinogenesis. 2008;29(3):666-672.[39] Hahn JY, Cho HJ, Bae JW, et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem. 2006; 281(41):30979-30989. |